Merck, Gardasil and Safety Suit

Merck prevails in US safety litigation over Gardasil HPV vaccine
A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent cervical and other cancers caused by the human papillomavirus and one of the drugmaker's best-selling products.
Federal Judge Rules in Merck’s Favor in Gardasil Safety Suit
A federal judge ruled in Merck & Co.’s favor in a safety lawsuit over its Gardasil vaccine, allowing the drugmaker to sidestep more than 200 cases claiming the company concealed safety risks.
Good Day for Gardasil as Merck Wins Safety Suit, Drops $1B for Manufacturing Push
According to Judge Kenneth Bell, there is a lack of evidence to conclude that Merck willingly misrepresented the safety of its HPV vaccine Gardasil to patients and prescribers.
Merck prevails in Gardasil safety litigation
A federal judge has ruled in favor of Merck in litigation accusing the drugmaker of concealing the risks of Gardasil, a vaccine to prevent cervical and other fatal cancers. The decision made public on Tuesday by U.
Judge: 'Evidence Is Lacking' to Impose Warning on HPV Vaccine Gardasil
U.S. District Judge Kenneth Bell, who is overseeing the Gardasil multidistrict litigation in the Western District of North Carolina, sided with Merck on its implied preemption defense, granting summary judgment to potentially hundreds of cases.
Federal judge rules in favor of drugmaker in HPV vaccine case
A federal judge granted summary judgment in favor of Merck for part of the litigation involving the HPV vaccine, Gardasil. The rest of the case is still going on.
Fierce Pharma4d
Merck defeats claims it should have added safety warnings to Gardasil's label, knocking out 200-plus lawsuits
In a decision signed Monday, North Carolina federal judge Kenneth Bell granted Merck’s motion to dismiss the claims of ...
Gardasil maker completes $1B North Carolina expansion — more growth on the way
New facility will manufacture HPV vaccines Gardasil and Gardasil 9. Merck plans to invest $8 billion more in U.S. by 2028. A ...
Seeking Alpha4d
Merck scores victory in Gardasil lawsuits as judge questions evidence
A federal judge in North Carolina on Tuesday granted an order for summary judgment in favor of Merck (NYSE:MRK) regarding lawsuits accusing the drugmaker of failing to warn consumers its Gardasil ...
Fierce Pharma5d
Merck opens $1B Gardasil manufacturing facility in North Carolina
At its sprawling complex in Durham, N.C., Merck has opened a new $1 billion, 225,000-square-foot manufacturing plant slated ...
Union Leader4d
Merck prevails in safety litigation over Gardasil HPV vaccine
A federal judge ruled in favor of Merck in litigation accusing it of concealing the risks of Gardasil, a vaccine to prevent ...
Notable healthcare headlines for the week: Merck, Novo Nordisk, J&J and Roche in focus
Wall Street's major averages closed in the green on Friday, but the benchmark S&P 500 (SP500) posted a four-week losing streak for the first time since early August last year as President Donald Trump ...
The Business Journals4d
Merck completes $1B North Carolina expansion — more growth on the way
The company began construction on the now open facility in 2019 to increase manufacturing capabilities for its Gardasil vaccine, which protects against HPV (Human papillomavirus). Merck last year ...
pharmaphorum4d
MSD opens $1bn plant for HPV vaccine in the US
MSD has opened the doors of a $1 billion manufacturing facility at its site in Durham, North Carolina, that will be used to ...